cgh-asgcr (Agenda)

Symposium Agenda

Dates: Wednesday, March 10 and Thursday, March 11, 2021

Start time: 1:00PM UTC | 8:00AM US EST

End time: 4:00PM UTC | 11:00AM US EST

Agenda as of March 3, 2021. Times shown are US Eastern Standard Time (EST).

Day One: Wednesday, March 10th

8:00 - 8:25 AM

Welcome and Opening Remarks: “Global Cancer Research and Control: Looking Back and Charting a Path Forward”

Miriam Mutebi, MD, Breast Surgical Oncologist, Aga Khan University Hospital, Nairobi, Kenya

Norman E. Sharpless, MD, Director, U.S. National Cancer Institute, Rockville, MD, United States

Julie R. Gralow, MD, Chief Medical Officer, American Society of Clinical Oncology, Alexandria, VA, United States

Cesaltina Lorenzoni Ferreira, MD, PhD, Head, Cancer Control Program, Ministry of Health, Maputo, Mozambique

8:25 - 9:40 AM

Panel: Building Towards Resilience in Cancer Care, Control, and Research

This panel will focus on building resilient health systems, including how leaders, researchers and implementers are doing this across the globe. What does building resilient health systems mean? How do you prioritize interventions that promote stronger health systems? How can countries access technical information to make decisions around health programs? How can scientific evidence affect the interplay between policy and implementation to build resilience? 

This panel will focus on critical gaps that have emerged in the face of acute threats and emergencies (e.g., COVID-19, climate change, politics, etc.) and what it will take to build systems for global cancer research, prevention and control that can continue to function during these hardships. The panel will consider critical issues around and existing models for building and retaining capacity in cancer prevention and control programs using a systems approach. Specific solutions-based examples will focus on strengthening primary care; developing and implementing health emergency and risk management strategies; evidence-based decision making and clinical strategies to ensure the clinical continuum of care; and the role of leadership in policy, dissemination, and implementation of strategies to build resilience in cancer care, control and research.
 

Panel Chair:

Anne F. Rositch, PhD, MSPH, Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States

Panel Speakers:

Rifat Atun, MBBS, MBA, DIC, FRCGP, FFPH, FRCP, Professor of Global Health Systems, Department of Global Health & Population, Department of Health Policy & Management, Harvard T.H. Chan School of Public Health; Department of Global Health and Social Medicine, Harvard Medical School, Cambridge, MA, United States

David Peters, MD, DrPH, Edgar Berman Chair in International Health, Director, Alliance for a Healthier World, Professor, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

Karla Unger-Saldaña, MD, MSc, Researcher, Instituto Nacional de Cancerología, Mexico City, Mexico 

Cyprien Shyirambere, MD, Oncology Program Director, Partners in Health, Butaro Comprehensive Cancer Center, Butaro, Rwanda 

Sharon Kapambwe, MD, Assistant Director, Cancer Control, Ministry of Health, Lusaka, Zambia

9:40 - 9:45 AM

Break | Scientific Poster Slide Presentation

Elise Garton, MS, Presidential Management Fellow, Center for Global Health, U.S. National Cancer Institute, Rockville, MD, United States

9:45 - 10:55 AM

Scientific Abstract Oral ‘Rapid Fire’ Session

The rapid-fire presentation format is an exciting oral presentation style, designed to allow for a succinct overview of research or program findings. This session will be a series of 10 rapid-fire presentations of selected abstracts, which were selected in a peer-review process based on overall score and relevance to priority topic areas and Symposium theme. Each rapid-fire presentation will be a prerecorded 5-minute individual presentation with the use of visual media (maximum 5 slides). Abstracts will be grouped by topic area selected by the abstract author. A live 3-minute question and answer discussion will follow each topic area.

Abstract Presentation List

 

Session Chairs:

Carl E. Allen, MD, PhD, Co-Director, Histiocytosis Program, Co-Director, Lymphoma Program, Director of Research, Global Hematology-Oncology Pediatric Excellence (HOPE), Associate Professor, Department of Pediatrics, Baylor College of Medicine/Texas Children’s Hospital, Houston, TX, United States

Linsey Eldridge, MPH, Cancer Research Training Award Fellow, Center for Global Health, U.S. National Cancer Institute, Rockville, MD, United States

10:55 - 11:00 AM

Day One Closing

Carl E. Allen, MD, PhD, Co-Director, Histiocytosis Program, Co-Director, Lymphoma Program, Director of Research, Global Hematology-Oncology Pediatric Excellence (HOPE), Associate Professor, Department of Pediatrics, Baylor College of Medicine/Texas Children’s Hospital, Houston, TX, United States

 

Day Two: Thursday, March 11th

8:00 - 8:10 AM

Welcome and Recap of Day One

Miriam Mutebi, MD, Breast Surgical Oncologist, Aga Khan University Hospital, Nairobi, Kenya

8:10 - 9:40 AM

Panel: Building Towards Equity 

This panel will focus on translation gaps between science conducted in low- and middle-income countries (LMICs), often funded by and involving scientists from high income countries, and the application, dissemination, and/or implementation of findings in the LMIC setting. The incredible successes of the oncology community and the contribution to those successes made through research in LMIC settings (e.g., early chemotherapy discovery, HPV vaccination trials) will be highlighted, while acknowledging that the global oncology community has not always ensured that the results of these studies find their way back to the people who played such a vital role in their success. While these big picture examples will be highlighted, the bulk of the session will be a facilitated discussion with a diverse group of experts about research collaborations, experiences with successes and failures in ensuring sustainability and local dissemination of research, and perspectives about how we ensure parity and equity in global oncology research collaborations.

Panel Chair:

Satish Gopal, MD, MPH, Director, Center for Global Health, U.S. National Cancer Institute, Rockville, MD, United States

Panel Speakers:

Lisa A. Newman, MD, MPH, FACS, FACSO, Chief, Breast Surgical Oncology Programs, Weill Cornell Medicine - New York Presbyterian Hospital Network, New York, United States

Valerie A. Paz-Soldan, PhD, MPH, Director of Tulane Health Offices for Latin America, Tulane University School of Public Health and Tropical Medicine, Lima, Peru 
 
CS Pramesh, MS, FRCS
, Director, Tata Memorial Hospital, Mumbai, India 

Verna Vanderpuye, MD, Radiation Oncologist, National Cancer for Radiotherapy, Korle Bu Teaching Hospital, Accra, Ghana 

9:40 - 9:50 AM 

Break | Scientific Poster Slide Presentation

Elise Garton, MS, Presidential Management Fellow, Center for Global Health, U.S. National Cancer Institute, Rockville, MD, United States

9:50 - 10:50 AM

Rachel Pearline Award Presentations and Keynote Addresses (2020 & 2021)

Session Chair:

Franklin Huang, MD, PhD, Assistant Professor, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States; Co-Founder, Global Oncology (non-profit organization)

2020 Awardee: 

Frederick Chite Asirwa, MD, Consultant Physician, Medical Oncologist & Hematologist, CEO, International Cancer Institute (ICI), Eldoret, Kenya

2021 Awardee:

Karla Alfaro, MD, MPH, Medical Director, Basic Health International, San Salvador, El Salvador 

10:50 - 11:00 AM

Closing Remarks

Miriam Mutebi, MD, Breast Surgical Oncologist, Aga Khan University Hospital, Nairobi, Kenya

Satish Gopal, MD, MPH, Director, Center for Global Health, U.S. National Cancer Institute, Rockville, MD, United States

 

sponsor logos